This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Measure of benefits used in the economic analysis
The measure of benefit used was survival or institutionalisation rates over a 1-year period. In additionally, the qualityadjusted life-years (QALYs) were calculated and included as a secondary measure of benefit. The health states were evaluated with the EuroQol (EQ-5D) at 6, 12, 26 and 52 weeks after stroke onset. The utility weights for health states were derived from a UK general population survey.
Direct costs
The direct costs included in the analysis were those of the health service and other formal care agencies. The categories covered were hospital resource use, therapy and other public sector services. Hospital and therapy data were extracted for each patient on an ongoing basis. Data on other public sector services were collected prospectively for each patient using an adapted version of the Client Service Receipt Inventory. For some costing items the authors used information from families, health and social services records, and direct observations of services provided. Resource use and the costs were reported separately. An exhaustive list of each category was provided in the paper. Local unit costs were used and were supplemented by national average costs when the former were not available. The costs were not discounted as the time horizon chosen was 12 months. The costs were expressed in 1997/98 prices and were inflated when appropriate using the NHS Executive hospital and community health services inflation index.
Statistical analysis of costs
The costs were treated stochastically. Descriptive statistics such as the mean, standard deviation (SD), mean difference, and 95% associated confidence intervals were reported. Means across the three groups were compared using a one-way analysis of variance with the Bonferroni procedure being used to adjust for multiple testing. Non-parametric methods were used to ensure the robustness of the parametric test. A chi-squared test was used to compare the proportion of avoided deaths or institutionalisations across the three groups.
Indirect Costs
The informal care received by the patients represented the indirect costs included in the analysis. For each patient, the amount of informal care received was based on the number of weeks in the year over which care was received.
Informal care costs were estimated using either the UK minimum wage rate (3.53/hour, the opportunity cost method) or the unit cost of a social services home help worker (10.61/hour, the replacement cost method). The authors stated that they used both methods as there is currently no agreement on which approach should be used. The costs were not discounted since the chosen time horizon was 12 months. The costs were expressed in 1997/98 prices and were inflated when appropriate using the NHS Executive hospital and community health services inflation index.
Currency

UK pounds sterling ().
Sensitivity analysis
A sensitivity analysis was performed to verify the impact of informal care on the overall costs. Minimum wage or home help worker rates were applied to study the effect of informal care on the results.
Estimated benefits used in the economic analysis
The number of patients who avoided death or institutionalisation at the 12-month follow-up was 129 (87%) for the stroke unit, 102 (69%) for the stroke team, and 109 (78%) for the domiciliary care group, (chi-squared 13.66, p<0.001).
Over the 12-month period, the mean QALYs were 0.297 (SD=0.257) for the stroke unit, 0.216 (SD=0.370) for the stroke team, and 0.221 (SD=0.344) for the domiciliary care group, (F2=2.78, p<0.063).
Cost results
Over the 12-month period, the total mean cost per patient, excluding informal care, was 11,450 (SD=9,745) for the stroke unit, 9,527 (SD=8,664) for the stroke team, and 6,840 (SD=9,353) for the domiciliary care group, (F2=8.96, p<0.000).
Over the 12-month period, when including informal care based on the minimum wage rate, the total cost per patient was 16,574 (SD=13,157) for the stroke unit, 12,512 (SD=10,369) for the stroke team, and 10,296 (SD=11,613) for the domiciliary care group, (F2=8.96, p<0.000); and based on the home help rate, the total cost per patient was 26, 738 (SD=26, 817) for the stroke unit, 18, 494 (SD=18, 785) for the stroke team, and 17,226 (SD=21,442) for the domiciliary care group (F2=7.57, p<0.001).
The authors reported a comprehensive costing of resource use in the paper, along with cost tables. The reader is referred to the paper for any specific item presented in the analysis.
Synthesis of costs and benefits
The costs and effects were combined using the incremental cost-effectiveness ratio (ICER). Uncertainty was handled through the use of cost-effectiveness acceptability curves. Dominance and extended dominance were studied before calculating the ICER.
The stroke team was dominated by domiciliary care on both outcome measures, from all cost perspectives, thus reducing the comparison to stroke unit versus domiciliary care.
The additional cost of avoiding an additional 1% of deaths and institutionalisations in the stroke unit group compared with domiciliary care ranged from 534 to 1,033, depending on the perspective adopted.
The ICERs per additional QALY gained ranged from 64,323 to 136,609, depending on the cost perspective taken.
The cost-effectiveness acceptability curve showed that domiciliary care had the highest probability of being costeffective across the full range of values reported for the willingness-to-pay for additional QALYs gained.
